Aberdeen_investor
11 Oct 2019
Thoughts on Future Market Cap Some say………………………… Tomascc52 has that video on constant replay…
tomasccc52
11 Oct 2019
Thoughts on Future Market Cap Loved the obsession post Aberdeen. My girlfriend asked how many times I am going to watch the part of the II interview when Mr Barder is asked about the 80 pct continuing on Med. His reaction is about as perfect as it gets.
Aberdeen_investor
11 Oct 2019
Thoughts on Future Market Cap I’m in Iraq these days and yes, there are some FUM share holders here too now
smashing1
11 Oct 2019
Thoughts on Future Market Cap Good to see some positivity on the ii board whilst sp so listless. Aberdeen - Enjoyed your FUM obsession post. I always imagined FUM would send you a special one-off product to help you recover from your triumphant streak through the city. I imagine it’s sub-zero up there already … lol
Aberdeen_investor
11 Oct 2019
Thoughts on Future Market Cap The world of Pharma is a funny world indeed. When these companies want something, they will pay handsomely to acquire it. I’ve even seen premiums of 500 percent being paid to closing share prices!! So let’s hope the phase 3 results exceed our expectations which is then followed by a few large companies trying to aggressively acquire this product
Lastemporer
10 Oct 2019
Thoughts on Future Market Cap Random news today I saw…RARX on the nasdaq was acquired by UCB for $2.1m. ([link] I then had a look at the RARX pipeline: [link] No drugs approved, 1 in P3… main product being: "Zilucoplan Ra Pharmaceuticals is developing zilucoplan for generalized myasthenia gravis (gMG), immune-mediated necrotizing myopathy (IMNM), and other tissue-based complement-mediated disorders with high unmet medical need. The product is designed for convenient, subcutaneous (SC) self-administration. Zilucoplan is a synthetic, macrocyclic peptide discovered using Ra Pharmaceuticals’ powerful proprietary drug discovery technology. The peptide binds complement component 5 (C5) with sub-nanomolar affinity and allosterically inhibits its cleavage into C5a and C5b upon activation of the classical, alternative, or lectin pathways." This is a rare disease like all their pipeline, it’ also very complex , I imagine the trials needed and data for liver toxicity / damage etc is so much more complex for any study to approval. Back to marketcap… are we that FAR off / different at 75m?
Lastemporer
10 Oct 2019
Thoughts on Future Market Cap It also references Placebo as 25%. Barder is back on taking investor questions? Alternatively, please contact James Barder, Chief Executive or Angela Hildreth, Finance Director and Chief Operating Officer at: Futura Medical plc Surrey Technology Centre 40 Occam Road Guildford Surrey GU2 7YG [email protected]
Aberdeen_investor
10 Oct 2019
Thoughts on Future Market Cap How long have you had this daily FUM obsession? Has it got to the point where you have noticed “FUM†on number plates? Has it got to the point where you are sitting in meetings and when someone writes “MED†on a whiteboard against a list of priorities, you instantly think it’s MED2005 and not “MEDIUM� Has it got to the point where your internet history is awash with searches on Erectile Dysfunction and Condoms? Has it got to the point where every company you have worked with, you have managed to get everyone siting around you to buy into FUM and become shareholders? Has it got to the point where you have spent a weekend phoning up Pharmacies in Saudi Arabia asking if they still stocked SuperManex Condoms? Has it got to the point where people you work with refer to the product as “Aberdeen’s co…ck rub� Has it got to the point where you have dreamt about attending a Futura Medical AGM and could not get to the front row because it was attended by dwarf’s?
Aberdeen_investor
10 Oct 2019
Thoughts on Future Market Cap The new website gives much more detailed information on patent protection and data protection laws and exclusivity periods when it comes to a topical treatment such as MED. I encourage everyone to take a read. Based on historical experiments measuring the blood flow by Doppler ultrasound using various concentrations of MED, we have seen that there was a significant improvement as the MED concentration was increased. There was almost nothing at the lower doses and then all of a sudden a significant improvement when it was increased to the 0.2%. I, for one feel Futura Medical has been very cautious when increasing the doses (for example only the 0.2% dose was used in the phase 2 trial) I think with the levels of MED Concentrations used in the phase 3 trials, we will all be in for a very good surprise. Especially when you look at the PK Data (which in my opinion de-risked the trial to some extent). Had the PK Data shown that not all of the MED was absorbed into the blood stream as the concentration was increased, I would have been a bit more hesitant, however thankfully there was an excellent dose related response. Hopefully we all see the following HEADLINE DATA
fx2452
10 Oct 2019
Thoughts on Future Market Cap All this investment perhaps gives a hint that positive news may be on the horizon? Let’s hope so. Well spotted our imperial friend. GLA
Aberdeen_investor
10 Oct 2019
Thoughts on Future Market Cap I see there is a James Barder look alike on the new website
Lastemporer
10 Oct 2019
Thoughts on Future Market Cap From my daily FUM obsession I see there is a new website. There seems to be some more stats on MED commercials which may help you fx related to marketcap. Also lots of good quotes from the panel expert supporters in the Urology world. Event calendar looks busy: Search EVENT CALENDAR Home Media Event calendar Representatives from Futura Medical will be in attendance at the following conferences and events. If you wish to meet our representatives, please contact us at [email protected]. 20th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America (SMSNA) Nashville, US 24 October 2019 27 October 2019 View Jefferies 2019 London Healthcare Conference London, UK 20 November 2019 21 November 2019 View J.P. Morgan 38th Annual Healthcare Conference (JPM 2020) San Francisco, US 13 January 2020 16 January 2020 View 22nd Congress of the European Society for Sexual Medicine (ESSM) Prague, Czech Republic 23 January 2020 25 January 2020.
Emtee
02 Oct 2019
Today's RNS Ignore. I see Tim Holland is presenting on the Saturday at the SMSNA conference at the end of October. In Nashville.
Emtee
02 Oct 2019
Today's RNS Does anyone know which US conference Futura are presenting at this month?
smashing1
01 Oct 2019
Today's RNS Good link from LSE bb: Labiotech.eu – 1 Oct 19 Taking Your Product Forward Against All Odds Having to let go of your flagship product after years of development is not easy. Nor is fundraising for another product after a major partner backs out -- a challenge that Angela Hildreth had to confront when she joined the British company Futura... Still saying December.
